Journal Menu
► Journal MenuJournal Browser
► Journal BrowserSpecial Issue "Anticancer Drug Targeting Using Novel Delivery Systems and Medical Devices"
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Targeting and Design".
Deadline for manuscript submissions: 31 July 2023 | Viewed by 3381
Special Issue Editors
Interests: controlled drug delivery; nanoparticles; targeted therapy; anticancer drug delivery systems; nanotechnology; antibacterials for superbugs; wound healing; veterinary formulations
Special Issues, Collections and Topics in MDPI journals
Interests: controlled drug delivery; polymeric nanoparticles; liposomes; nanoemulsions; lipid nanoparticles; chronotherapeutics; solubility enhancement
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Cancer is one of the leading causes of death worldwide and as per the cancer reports, it is expected that by the year 2040, the cases may rise by 29.5 million. A plethora of strategies are available in the market for the treatment of cancer, which has been widely used in clinics. These include chemotherapy, immunotherapy, targeted therapies, and a combination of radiation-chemotherapy. Despite these strategies, multidrug resistance remains a major obstacle in the effectiveness of cancer therapy. To combat this, novel targeted approaches encompassing organic and inorganic nanocarriers, cancer stem cell therapy, biomaterials have been explored for improving its therapeutic efficacy over the conventional approaches. These help in the preferential uptake of the therapeutic agents by the tumor cells leading to their eradication with reduced side effects and alleviating the likelihood of multidrug resistance.
This Special Issue focuses on an assemblage of the key findings and contributions focused on the area of novel drug delivery systems and medical devices research in cancer therapy, diagnostics and bioimaging. In this issue, we welcome original research, short communications, and reviews with key topics comprising of the novel, innovative therapeutic approaches involving the synthesis, targeted drug delivery for theranostics purposes, multimodal drug therapy for combating multidrug resistance, biomedical devices addressing the fields of cancer therapy and diagnostics.
Prof. Dr. Sanjay Garg
Dr. Usha Y. Nayak
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
